Samsara BioCapital »

Bicara Therapeutics shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Bicara Therapeutics shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2024-09-30 $892k 35k 25.47

More positions owned by Samsara BioCapital

Cargo Therapeutics (CRGX)
Mineralys Therapeutics (MLYS)
Scholar Rock Hldg Corp (SRRK)
Neurogene (NGNE)
Alumis Common Stock (ALMS)
Arcellx Common Stock (ACLX)
Lenz Therapeutics (LENZ)
Nkarta (NKTX)
Eliem Therapeutics (ELYM)
Avadel Pharmaceuticals Com Shs (AVDL)
Zymeworks Del (ZYME)
Acelyrin (SLRN)
Contineum Therapeutics Cl A (CTNM)
Jasper Therapeutics Com New (JSPR)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Samsara BioCapital

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Deerfield Management Company
Braidwell
T. Rowe Price Associates
Fairmount Funds Management
Baker Bros. Advisors
Blackstone Group
First Turn Management
Vestal Point Capital
Point72 Asset Management
Woodline Partners
OrbiMed Advisors
Citadel Advisors

View all funds holding Bicara Therapeutics